Publication
TGA shelves biosimilar and generic transparency measures
In late 2020, following almost 18 months of public and industry consultations conducted by the Therapeutic Goods Administration (TGA).
Publication | January 13, 2013
In my January 2015 column,1 I discussed December 2014 proposed revisions to the international risk-based capital requirements using the Standardized Approach. The proposed revisions were issued by the Basel Committee, which develops international capital standards. After review of the comments and analysis of a quantitative study regarding the impact of the proposal on affected institutions, the Basel Committee issued a re-proposal of the changes for comment on Dec. 10, 2015.2 Comments are due by March 21, 2016. This month’s column will discuss highlights of the re-proposal.
Under current Basel III capital standards, certain large banking organizations, with regulatory approval, can use their sophisticated internal risk-based models to determine the risk weight of their assets, called the Internal Ratings-Based Approach. The remaining banking organizations use the Standardized Approach. The standardized risk-based capital calculations as amended over the years are derived from the original risk-based capital standards issued in 1988.
Read the full article: Revised proposed changes to capital requirements
Publication
In late 2020, following almost 18 months of public and industry consultations conducted by the Therapeutic Goods Administration (TGA).
Publication
The NSW Environment Protection Authority (EPA) recently released for public comment its draft Climate Change Assessment Requirements (CCARs) and draft Guide for Large Emitters (Guide).
Publication
The introduction of a minimum stockholding obligation under the Fuel Security Act 2021 (Cth) has underscored the importance of traditional liquid fuels to safeguarding Australia’s energy security as it navigates the energy transition.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023